D+817
Today is 2024. 12. 09

Scientific Program

  • Home
  • Program
  • Scientific Program

※Some lectures will be pre-recorded.

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

From reading the genome for risk to rewriting it for cardiovascular health

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 6
Adipose tissue & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 6 Adipose tissue & atherosclerosis

Chairpersons

한진 (인제의대), 노정현 (인제의대)

Panels

김남훈 (고려의대), 전성완 (순천향의대)

09:45 - 10:05

Novel mechanisms for lipogenesis

Gina Lee (University of California Irvine, USA)

10:05 - 10:25

Local & systemic effect of organ fat deposition

최성희 (서울의대)

10:25 - 10:45

Sex-dependent NAD+ metabolism in the liver & adipose tissue

Ji-Young Lee (University of Connecticut, USA)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Symposium 10
Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution
September 16(Fri) 13:35 - 15:05
Symposium 10 Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution

Chairpersons

정명호 (전남의대), 김성래 (가톨릭의대)

Panels

김경수 (차의대), 박재형 (고려의대)

13:35 - 13:55

Current evidence on risk stratifying factors in Koreans

허지혜 (한림의대)

13:55 - 14:15

How much different event risk do Koreans have compared to European descendants?

안성복 (이화의대)

14:15 - 14:35

How to select of low risk individuals to avoid pharmacotherapy?

김학령 (서울의대)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 2
September 16(Fri) 15:15 - 16:15
Oral Presentation 2

Chairperson

권유욱 (서울대)

Panels

조아현 (가톨릭의대), 홍준화 (을지의대)

15:15 - 15:22

Prediction of future vascular events from thrombus analysis of Ischemic myopathy (TAOISM)

김정민 (서울의대)

15:22 - 15:29

Comparison of single-pill combination of moderate-intensity rosuvastatin & ezetimibe versus high-intensity rosuvastatin in atherosclerotic cardiovascular disease patients with type 2 diabetes

최효인 (성균관의대)

15:29 - 15:36

Protocatechuic acid prevents heart failure in isoproterenol-infused mice by downregulating Kmo

기해진 (전남의대)

15:36 - 15:43

Rh1 ginsenoside suppressed lipopolysaccharide-induced endothelial cell inflammation & apoptosis by inhibiting endoplasmic reticulum stress & TLR4-mediated STAT3/NF-kB pathway

진유진 (충남대)

15:43 - 16:08

Q&A

September 16(Fri)
16:15 - 17:45
Symposium 13
Debate on new Korean guidelines on dyslipidemia: treatment
September 16(Fri) 16:15 - 17:45
Symposium 13 Debate on new Korean guidelines on dyslipidemia: treatment

Chairpersons

김치정 (중앙의대), 장학철 (서울의대)

Panels

김병진 (성균관의대), 정인경 (경희의대)

16:15 - 16:35

Korean evidence on target LDL-C levels

문민경 (서울의대)

16:35 - 16:55

Are current Western LDL-C targets for each risk groups cost-effective in Koreans?

김상현 (서울의대)

16:55 - 17:15

When is clinically appropriate to start anti-PCSK9 Abs?

남창욱 (계명대)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 1 [Celltrionpharm]
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 1 [Celltrionpharm]

Chairperson

이우제 (울산의대)

Panels

서지아 (고려의대), 장지용 (연세의대)

08:00 - 08:20

Pioglitazone & Cardiovascular Risk Reduction

노정현 (인제의대)

08:20 - 08:30

Discussion

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 3 [Organon]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 3 [Organon]

Chairperson

이홍규 (서울의대)

Panels

윤혁준 (계명의대), 한승진 (아주의대)

12:00 - 12:20

Recent Update on Combination Therapy for High risk ASCVD patients

윤종찬 (가톨릭의대)

12:20 - 12:30

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

From reading the genome for risk to rewriting it for cardiovascular health

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 7
New regulators of dyslipidemia & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 7 New regulators of dyslipidemia & atherosclerosis

Chairpersons

In Kyeom Kim (Kyungpook National University, Korea), Soon Jun Hong (Korea University, Korea)

Panels

Eun Hee Koh (University of Ulsan, Korea)

09:45 - 10:05

Validation of metabolic targets in adipose tissue for ASCVD: focus on the KLF14 locus

Mete Civelek (University of Virginia, USA)

10:05 - 10:25

Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis & paracrine fibrotic signalling

Judith Sluimer (Maastricht University, Netherlands)

10:25 - 10:45

Understanding the phenotypic changes of vascular smooth muscle cells during atherosclerosis

Jae-Hoon Choi (Hanyang University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Food & Nutrition Workshop
Cardiometabolic disease & customized nutrition management
September 16(Fri) 13:35 - 15:05
Food & Nutrition Workshop Cardiometabolic disease & customized nutrition management

Chairpersons

이명숙 (성신여대), 정효지 (서울대)

Panels

서존 (순천향의대), 임현정 (경희대)

13:35 - 13:55

Customized functional food based on big data

김지영 (서울대)

13:55 - 14:15

Customized prevention of metabolic disease in Koreans using omics technology

김민주 (한남대)

14:15 - 14:35

Healthcare program using digital health device

김영인 (주식회사 가지랩)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 3
September 16(Fri) 15:15 - 16:15
Oral Presentation 3

Chairpersons

Hyuk-Sang Kwon (The Catholic University of Korea, Korea), Sungha Park (Yonsei University, Korea)

Panels

Hyun Min Kim (Chung-Ang University, Korea), Su Jin Jeong (Sejong General Hospital, Korea)

15:15 - 15:22

Cardiovascular risk factor profiles of familial hypercholesterolaemia patients with & without pathogenic FH candidate gene variants in the Malaysian community

Aimi Zafira Razman (Universiti Teknologi MARA, Malaysia)

15:22 - 15:29

Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomized waiting list controlled open-label trial

Akihiro Nomura (Kanazawa University, Japen)

15:29 - 15:36

Dyslipidemia & type 2 diabetes among Filipino adults

Cherry Ann Durante (Emilio Aguinaldo College Manila, Philippines)

15:36 - 15:43

The relationship between total cholesterol level & oxidative stress in the liver tissue of the hyperlipidemic rat model after the intervention with synbiotic beverage

Rafik Prabowo (Universitas Islam Indonesia, Indonesia)

15:43 - 15:50

Determination of pathogenicity in ABCG5 & ABCG8 gene among Japanese dyslipidemic patients

Nobuko Kojima (Kanazawa University, Japan)

15:50 - 16:15

Q&A

September 16(Fri)
16:15 - 17:45
Publication Committee Symposium
September 16(Fri) 16:15 - 17:45
Publication Committee Symposium

Chairpersons

박용식 (경희대), 김정민 (서울의대)

16:15 - 16:20

JLA Award Ceremony

16:20 - 16:35

Regulation of macrophage activation & differentiation in atherosclerosis

박성호 (유니스트)

16:35 - 16:50

Prospect of artificial intelligence based on electronic medical records

김헌성 (가톨릭의대)

16:50 - 17:05

Intravital two-photon imaging of dynamic alteration of lipid droplet in a live animal model

김필한 (카이스트)

17:05 - 17:20

Statin therapy & the risk of osteoporotic fractures in patients with metabolic syndrome: a nested case-control study

김경진 (고려의대)

17:20 - 17:35

Metabolism & health impacts of dietary sugars

Cholsoon Jang (University of California Irvine, USA)

17:35 - 17:45

Q&A

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 2 [Organon]
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 2 [Organon]

Chairperson

Seonghoon Choi (Hallym University, Korea)

Panels

Bo Kyung Koo (Seoul National University, Korea), Hyemoon Chung (Kyung Hee University, Korea)

08:00 - 08:20

Management of uric acid in hypertensive patients: role of losartan

Hack-Lyoung Kim (Seoul National University, Korea)

08:20 - 08:30

Discussion

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 4 [JW Pharmaceutical]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 4 [JW Pharmaceutical]

Chairperson

Jeong Euy Park (Sungkyunkwan University, Korea)

Panels

Bong-Ki Lee (Kangwon National University, Korea), Suk Chon (Kyung Hee University, Korea)

12:00 - 12:20

Cutting edge care of Pitavastatin with Ezetimibe combination therapy

Jun Hwa Hong (Eulji University, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Donghoon Choi (Yonsei University, Korea)

09:00 - 09:40

From reading the genome for risk to rewriting it for cardiovascular health

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 8
High CV risk group: is it properly defined?
September 16(Fri) 09:45 - 11:15
Symposium 8 High CV risk group: is it properly defined?

Chairpersons

Myung-A Kim (Seoul National University, Korea), Woo Je Lee (University of Ulsan, Korea)

Panels

Hack-Lyoung Kim (Seoul National University, Korea), Jung-Joon Cha (Korea University, Korea)

09:45 - 10:05

What is the role of a polygenic risk score in CV risk assessment?

Amit Khera (Verve Therapeutics, USA)

10:05 - 10:25

Refinement of CV risk in current very high & high risk groups

Hyeon Chang Kim (Yonsei University, Korea)

10:25 - 10:45

Risk stratification according to age groups in new prevention guidelines

Kwang-il Kim (Seoul National University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

11:30 - 12:00

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University of Science & Technology, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

Goo Taeg Oh (Ewha Womans University, Korea)

12:55 - 13:35

Senescence & vascular smooth muscle cell plasticity

Martin Bennett (University of Cambridge, UK)

September 16(Fri)
13:35 - 15:05
Symposium 11
Inflammation in progression & inhibition of atherosclerosis
September 16(Fri) 13:35 - 15:05
Symposium 11 Inflammation in progression & inhibition of atherosclerosis

Chairpersons

Hyo-Soo Kim (Seoul National University, Korea), Young-Guen Kwon (Yonsei University, Korea)

Panels

Young-Kook Kim (Chonnam National University, Korea), Chang Hee Jung (University of Ulsan), Korea)

13:35 - 13:55

Macrophage diversity in inflammation & homeostasis

Ichiro Manabe (Chiba University, Japan)

13:55 - 14:15

Inflammation & hematopoiesis in atherosclerosis

Katey Rayner (University of Ottawa, Canada)

14:15 - 14:35

Immune cell repertoire & novel therapeutic target of aortic aneurysm

Seung-Jun Lee (Yonsei University, Korea)

14:35 - 15:00

Discussion

September 16(Fri)
15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence & Young Investigator
Scientific Excellence Award Lecture
September 16(Fri) 15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence & Young Investigator
Scientific Excellence Award Lecture

Chairpersons

Myung A Kim (Seoul National University, Korea), Donghoon Choi (Yonsei University, Korea)

15:15 - 15:20

2022 KSoLA Awards Ceremony for Scientific Excellence & Young Investigator

15:20 - 15:40

TG lowering: hope vs. hype?

Sang-Ho Jo (Hallym University, Korea)

15:40 - 15:45

Q&A

September 16(Fri)
16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium)
Impact of aging of vascular cells on atherosclerosis & its protection
September 16(Fri) 16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium) Impact of aging of vascular cells on atherosclerosis & its protection

Chairperson

Sang Hong Baek (The Catholic University of Korea, Korea)

Panels

Kwang-il Kim (Seoul National University, Korea), Kyu-Tae Kim (Ajou University, Korea)

16:15 - 16:35

Aging as risk factor & therapeutic target in atherosclerosis

Sungha Park (Yonsei University, Korea)

16:35 - 16:55

Targeting senescent cells as a novel therapeutic strategy for lifestyle-related disease

Tohru Minamino (Juntendo University, Japan)

16:55 - 17:15

What effect do cardiovascular medications & diet have on vascular aging?

Kenichi Tsujita (Kumamoto University, Japan)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 5 [Viatris]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 5 [Viatris]

Chairperson

Hyun Ho Shin (Asan Chungmu Hospital, Korea)

Panels

Jae-seung Yun (The Catholic University of Korea, Korea), Jun Won Lee (Yonsei University, Korea)

12:00 - 12:20

What are the optimal treatment options of dyslipidemia management for your
patients? based on LDL-C lowering continuum

So-Yeon Choi (Ajou University, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
09:45 - 11:15
Symposium 9
Update on non-pharmacological control of ASCVD risk
September 16(Fri) 09:45 - 11:15
Symposium 9
Update on non-pharmacological control of ASCVD risk

Chairpersons

Ick Mo Chung (Ewha Womans University , Korea), Sung Nim Han (Seoul National University, Korea)

Panels

Oh Yoen Kim (Dong-A University, Korea), Yeon-Kyung Choi (Kyungpook National University, Korea)

09:45 - 10:05

Cardiovascular disease & the bone marrow

Matthias Nahrendorf (Harvard Medical School, USA)

10:05 - 10:25

The dietary pattern approach to prevent cardiovascular disease. Dietary effects on HDL subspecies may contribute benefits

Frank Sacks (Harvard Medical School, USA)

10:25 - 10:45

Trends in dietary quality & cardiometabolic risks among Korean adults

Min-Jeong Shin (Korea University, Korea)

10:45 - 11:10

Discussion

September 16(Fri)
13:35 - 15:05
Symposium 12 (EAS/APSAVD/JAS Joint Symposium)
Dyslipidaemia
September 16(Fri) 13:35 - 15:05
Symposium 12 (EAS/APSAVD/JAS Joint Symposium)
Dyslipidaemia

Chairpersons

Jaetaek Kim (Chung-Ang University, Korea), Richard O’Brien (University of Melbourne, Australia)

Panels

Jae Hyuk Lee (Myongji Hospital, Korea), Seung Jin Han (Ajou University, Korea)

13:35 - 13:55

Dyslipidaemia - new treatments for ApoC3 & ANGPTL3

Brian Tomlinson (Macau University of Science & Technology, China)

13:55 - 14:15

Novel selective PPARa modulator pemafibrate for dyslipidemia & nonalcoholic fatty liver disease (NAFLD)

Shizuya Yamashita (Rinku General Medical Center, Japan)

14:15 - 14:45

New treatment targets beyond LDL-C in dyslipidaemias

Alberico L. Catapano (University of Milan, Italy)

14:45 - 15:05

Discussion

September 16(Fri)
16:15 - 17:45
Symposium 15 (APSAVD/KSoLA Joint Symposium)
COVID-19 & cardiovascular risk
September 16(Fri) 16:15 - 17:45
Symposium 15 (APSAVD/KSoLA Joint Symposium)
COVID-19 & cardiovascular risk

Chairpersons

Young-Bae Park (Seoul National University, Korea), Edward Janus (University of Melbourne, Australia)

Panels

Hong Nyun Kim (Kyungpook National University, Korea), Jung Ho Heo (Kosin University, Korea)

16:15 - 16:35

Impact of risk factors & medications on COVID-19 outcomes

In Sook Kang (Ewha Womans University, Korea)

16:35 - 16:55

Effect of COVID-19 on dyslipidemia & vascular disease

Edward Janus (University of Melbourne, Australia)

16:55 - 17:15

Benefit & harm of COVID-19 vaccines in ASCVD

Ta-Chen Su (National Taiwan University, Taiwan)

17:15 - 17:40

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 6 [Boehringer Ingelheim/Lilly]
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 6 [Boehringer Ingelheim/Lilly]

Chairperson

Shung Chull Chae (Kyungpook National University, Korea)

Panels

Hye-Mi Kim (Chung-Ang University, Korea), Yeoree Yang (The Catholic University of Korea, Korea)

12:00 - 12:20

How does empagliflozin connect to CRM : HF underappreciated complication of T2D

Sang-Hun Shin (Ewha Womans University, Korea)

12:20 - 12:30

Discussion

September 16(Fri)
15:15 - 15:55
Moderated Poster Presentation 1
September 16(Fri) 15:15 - 15:55
Moderated Poster Presentation 1

Chairperson

김소헌(인하의대)

Panels

김성애(한림의대), 이재혁(명지병원)

15:15 - 15:23

Oasl1 deficiency promotes eNOS mRNA degradation, accelerating endothelial dysfunction & atherogenesis

김태경 (이화여대)

15:23 - 15:31

Loss of myeloid-PCSK9 improves cardio-protection against acute myocardial infarction

문신혜 (이화여대)

15:31 - 15:39

Peroxiredoxin 3 preserves cardiac function by regulating mitochondrial quality control 

손성근 (이화여대)

15:39 - 15:47

HMGB1 mediates MCP-1 expression in mechanically stressed vascular smooth muscle cells

김지원 (부산대)

September 16(Fri)
15:15 - 15:55
Moderated Poster Presentation 2
September 16(Fri) 15:15 - 15:55
Moderated Poster Presentation 2

Chairperson

Ung Kim (Yeungnam University, Korea)

Panels

Yong Sook Kim (Chonnam National University, Korea), Heung Yong Jin (Jeonbuk National University, Korea)

15:15 - 15:23

Cr6 interacting factor 1 deficiency increases homocysteine production in vascular endothelial cells

Cuk Seong Kim (Chungnam National University, Korea)

15:23 - 15:31

17 β-Estradiol Increases APE1/Ref-1 Secretion in vascular endothelial cells : involvement of calcium-dependent exosome pathway

Yuran Lee (Chungnam National University, Korea)

15:31 - 15:39

PFKFB3 & its role on ECM dependent vascular inflammation

Jenita Immanuel (Inje University, Korea)

15:39 - 15:47

PCSK9 deficient heart-derived ANP promotes cardiac survival after myocardial infarction

Na Hyeon Yoon (Ewha Womans University, Korea)

September 16(Fri)
15:05 - 15:55
Moderated Poster Presentation 5 (APSAVD Young Investigator)
September 16(Fri) 15:05 - 15:55
Moderated Poster Presentation 5 (APSAVD Young Investigator)
MP5-01

Fenofibrate lowers cardiac lipid accumulation & attenuates diabetic cardiomyopathy in db/db mice

Jiwon Park (GIST, Korea)

MP5-02

In vitro & in silico inhibition of IL-6 & NF-κB by Nigella sativa oil & thymoquinone as potential anti atherogenic agent

Al aina Yuhainis Firus Khan (Universiti Teknologi MARA, Malaysia)

MP5-03

Coronary risk factor profile amongst premature coronary artery disease patients according to different age categories

Sukma Azureen Nazli (Universiti Teknologi MARA, Malaysia)

MP5-04

Genetic variations of ABCG5 & ABCG8 genes among clinically diagnosed fh patients attending primary care clinics in Malaysia

Yung An Chua (Universiti Teknologi MARA, Malaysia)

MP5-05

Genetic landscape of pathogenic variants in familial hypercholesterolaemia candidate genes among patients attending primary care clinics in Malaysia

Nur Syahirah Shahuri (Universiti Teknologi MARA, Malaysia)

MP5-06

Prediction rate of pathogenic variants diagnosed by various diagnostic criteria among familial hypercholesterolaemic patients attending primary care clinics

Sukma Azureen Nazli (Universiti Teknologi MARA, Malaysia)

MP5-07

Pharmacologic activation of angiotensin-converting enzyme II alleviates diabetic cardiomyopathy in db/db mice by reducing reactive oxidative stress

Woo ju Jeong (GIST, Korea)

MP5-08

Body type parameters predict cerebral small vessel disease

Ki-Woong Nam (Seoul National University, Korea)

MP5-09

A comparison of statin treatment algorithms for primary prevention in statin-naive Filipino patients

Bayani Pocholo Maglinte (Cebu Velez General Hospital, the Philippines)

Sponsored by